Opioid analgesic with monoamine reuptake inhibition

This page covers all Opioid analgesic with monoamine reuptake inhibition drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mu-opioid receptor; norepinephrine transporter; serotonin transporter, Mu opioid receptor; norepinephrine transporter; serotonin transporter, Mu opioid receptor; norepinephrine and serotonin transporters.

Targets

Mu-opioid receptor; norepinephrine transporter; serotonin transporter · Mu opioid receptor; norepinephrine transporter; serotonin transporter · Mu opioid receptor; norepinephrine and serotonin transporters

Marketed (3)

• placebo and tramadol · University of Southern Denmark · Pain Management
  Tramadol is a synthetic opioid analgesic that inhibits reuptake of norepinephrine and serotonin while also acting as a weak mu-opioid receptor agonist to provide pain relief.
• Tramadol HCl · Labopharm Inc. · Pain Management
  Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.
• Tramadol IV (Tradonal® IV) · University Hospital, Ghent · Pain Management
  Tramadol is an opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.

Phase 3 pipeline (2)

• Tramadol 5% · Al-Azhar University · Pain Management
  Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and inhibits the reuptake of norepinephrine and serotonin to produce pain relief.
• Tramadol PR oral · Pfizer · Pain Management
  Tramadol is a synthetic opioid analgesic that binds to mu opioid receptors and also inhibits the reuptake of norepinephrine and serotonin to provide pain relief.

Patent intelligence

• opioid analgesic with monoamine reuptake inhibition patent landscape — aggregated cliff calendar, attackable patents, originator estates